- Home
- CLPS vs CLGN Comparison
CLPS vs CLGN Comparison
Compare CLPS & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPS
- CLGN
- Stock Information
- Founded
- CLPS 2005
- CLGN 2004
- Country
- CLPS Hong Kong
- CLGN Israel
- Employees
- CLPS N/A
- CLGN N/A
- Industry
- CLPS Computer Software: Prepackaged Software
- CLGN Industrial Specialties
- Sector
- CLPS Technology
- CLGN Health Care
- Exchange
- CLPS Nasdaq
- CLGN Nasdaq
- Market Cap
- CLPS 38.4M
- CLGN 44.1M
- IPO Year
- CLPS 2018
- CLGN N/A
- Fundamental
- Price
- CLPS $1.10
- CLGN $4.19
- Analyst Decision
- CLPS
- CLGN Strong Buy
- Analyst Count
- CLPS 0
- CLGN 2
- Target Price
- CLPS N/A
- CLGN $12.50
- AVG Volume (30 Days)
- CLPS 64.4K
- CLGN 18.1K
- Earning Date
- CLPS 10-18-2024
- CLGN 11-27-2024
- Dividend Yield
- CLPS 11.82%
- CLGN N/A
- EPS Growth
- CLPS N/A
- CLGN N/A
- EPS
- CLPS N/A
- CLGN N/A
- Revenue
- CLPS $142,812,726.00
- CLGN $689,000.00
- Revenue This Year
- CLPS N/A
- CLGN N/A
- Revenue Next Year
- CLPS N/A
- CLGN $670.03
- P/E Ratio
- CLPS N/A
- CLGN N/A
- Revenue Growth
- CLPS N/A
- CLGN N/A
- 52 Week Low
- CLPS $0.68
- CLGN $3.61
- 52 Week High
- CLPS $1.70
- CLGN $6.99
- Technical
- Relative Strength Index (RSI)
- CLPS 40.34
- CLGN 51.28
- Support Level
- CLPS $1.02
- CLGN $3.61
- Resistance Level
- CLPS $1.20
- CLGN $4.39
- Average True Range (ATR)
- CLPS 0.14
- CLGN 0.23
- MACD
- CLPS -0.03
- CLGN 0.09
- Stochastic Oscillator
- CLPS 33.33
- CLGN 59.79
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting service, Customized IT solution service, and other. Generating majority of its revenue from the IT consulting service.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.